Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
Clinical trial NCT06461949 · WITHDRAWN
Trial details
- NCT number
- NCT06461949
- Sponsor
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2024-07-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.